Media
2026-06-09
Presentation på Aktiespararnas Aktiedagarna 9 juni 2026
2026-05-27
Bolagspresentation och Q&A
2026-04-30
VD och CFO presenterar Q1 2026 med Q&A
2026-04-09
"The mechanism of action is unique and brilliant"
For over 40 years, Dr. Harin Padma-Nathan has been at the forefront of developing treatments for erectile dysfunction. In an interview in Dicot Pharma's 2025 annual report, he describes why LIB-01 captured his interest...
2026-04-06
How Dicot Pharma Is Rethinking Erectile Dysfunction from the Ground Up
A plant-derived compound with a novel mechanism, eight weeks of effect from three days of dosing, and a Phase 2A readout that challenges what treatment of erectile dysfunction actually means...